Antivirals / Antivirals / Cold and Flu / Internal Use

Amizone® (Amizon) 250 mg (20 coated tablets)

Brands: Farmak (Ukraine)

$23.40

Quantity

Amizone® (Amizon) 250 mg (20 coated tablets) quantity

Add to cart

Add to wishlist

Sku:

4a919cb81fcc

Brands:: Farmak (Ukraine)

Description

Buy Amizone Antiviral drug for the treatment and prevention of influenza and acute respiratory viral infections

Structure

1 tablet contains active ingredient: amizone® (enisamium iodide) 0.25 g

Pharmacological properties

Pharmacokinetics

After oral administration, Amizon® quickly enters the bloodstream, its maximum concentration in the blood is observed 2-2.5 hours after administration. The half-life is 13.5-14 hours, it is metabolized in the liver, but quickly excreted from the tissues (the half-life is 2-3 hours). It is excreted from the body by 90-95% in the urine in the form of metabolites.

Pharmacodynamics

Amizone® is a derivative of isonicotinic acid. It has an inhibitory effect on influenza viruses, has interferonogenic properties, increases the body’s resistance to viral infections, has anti-inflammatory, antipyretic and analgesic effects.

The antiviral effect of Amizone® is associated with its direct effect on the hemagglutinins of the influenza virus, as a result of which the virion loses its ability to attach to target cells for further replication.

The anti-inflammatory effect is the result of stabilization of cell and lysosomal membranes, slowing down the degranulation of basophils, antioxidant action, normalization of the level of prostaglandins, cyclic nucleotides and energy metabolism in the focus of inflammation. The antipyretic properties of this agent are due to the effect on the thermoregulatory centers of the brain. The analgesic effect of the drug is carried out through the reticular formation of the brain stem.

Amizon® enhances persistent immunity by increasing the level of endogenous interferon in blood plasma by 3-4 times, lysozyme and increasing the titer of antibodies to infectious agents, as well as cellular – by stimulating the functional activity of T-lymphocytes and macrophages. This agent is a powerful inducer of endogenous interferon.

Indications for use

– Treatment and prevention of diseases: influenza and respiratory viral infections; Infectious mononucleosis; measles, rubella, chickenpox, mumps infection; pellinosis (cat scratch disease); non-specific chemoprophylaxis of hepatitis A, E;

– As part of complex therapy: viral, viral-bacterial and bacterial pneumonia and tonsillitis; skin-articular form of erysipeloid; meningitis and meningoencephalitis of viral etiology; herpes infection; hepatitis A, E; pain syndromes in osteochondrosis, herniated intervertebral discs, arthritis, neuralgia.

Method of administration and dosage

Amizone® should be taken orally after meals without chewing. The maximum single dose is 1000 mg, the daily dose is 2000 mg. The recommended course of treatment, depending on the severity and etiology of the disease, is from 5 to 30 days.

Influenza and other respiratory viral infections

Treatment. Adults and children over 12 years old are prescribed 250-500 mg 2-4 times a day for 5-7 days; children from 6 to 12 years old are prescribed 125 mg 2-3 times a day for 5-7 days.

Prevention. Adults and children over 16 years old – 250 mg per day for 3-5 days, further – 250 mg 1 time in 2-3 days for 2-3 weeks; children 6-12 years old – 125 mg every other day for 2-3 weeks; children from 12 to 16 years old – 250 mg every other day for 2-3 weeks.

With meningoencephalitis, Amizon® is prescribed for adults at 250 mg 3 times a day for 10 days.

For the treatment of measles, rubella, chickenpox for adults and children over 16 years old – 500 mg 3 times a day; children 6-7 years old – 125 mg 3 times a day; children 8-12 years old – 125 mg 4 times a day; children 13-14 years old – 250 mg 3 times a day; children 14-16 years old – 250 mg 4 times a day.

For the treatment of mumps infection, adults and children over 14 years of age are prescribed 250 mg 4 times a day with an average severity of the disease and 500 mg 3 times a day with a severe course for 6-7 days; children 12-14 years old are prescribed 250 mg 3-4 times a day for 6-7 days.

For non-specific chemoprophylaxis of mumps infection, adults are prescribed 250 mg 2 times a day for 10-14 days.

In case of moderate infectious mononucleosis for adults and children over 12 years old – 250 mg of Amizon® 3-4 times a day and for children from 6 to 12 years old – 125 mg 3 times a day. In severe cases, the first 2-3 days for adults and children over 12 years old – 1500-2000 mg per day, for children from 6 to 12 years old – up to 1000 mg per day. After reaching the clinical effect, the dose can be halved.

For the treatment of fellinosis, adults and children over 14 years of age are prescribed 250 mg 3-4 times a day with moderate severity and 500 mg 3 times a day with a severe form of the disease. Children aged 6-9 years – 125 mg 3 times a day; children 10-14 years old – 125 mg 4 times a day.

For the skin-articular form of erysipeloid, adults – 500 mg 3 times a day for 7-14 days.

Viral hepatitis A, E. In complex therapy for adults – 250 mg 3 times a day for the first 5 days. For nonspecific chemoprophylaxis in adults – 250 mg 3 times a day.

In the complex therapy of pneumonia for adults – 250 mg 3 times a day for 10-15 days.

In the complex therapy of angina for adults – 250 mg 3-4 times a day for 5 days with an average severity of the disease; 500 mg 3-4 times a day for 7 days in severe disease.

For pain syndromes, adults are used 250-500 mg 3-4 times a day.

ADVERSE REACTIONS

The manifestations of adverse reactions are classified according to MedDRA terminology.

• From the immune system: hypersensitivity reactions.
• From the skin and subcutaneous tissue: rash, itching, urticaria, erythema, angioedema.
• From the gastrointestinal tract: dry mouth, dysgeusia (bitter taste in the mouth), swelling of the oral mucosa,
• hypersalivation, discoloration of the tongue (yellowing), nausea, vomiting, diarrhea, dyspepsia, abdominal
• pain, pain in the upper abdomen, bloating.
• From the respiratory system, chest and mediastinal organs: dyspnea, throat irritation.
• General disorders and disorders at the injection site: asthenia, peripheral edema.
• From the nervous system: headache, dizziness.
• Laboratory and instrumental data: increase in blood pressure, decrease in blood pressure.

Contraindications

– hypersensitivity to iodine preparations and to other components of the drug

– the presence of allergic reactions, regardless of the nature of the allergen in the history

– severe organic damage to the liver and kidneys

– first trimester of pregnancy

– children under 6 years old

Drug interactions

Amizone® enhances the effect of antibacterial and immunomodulating agents. A combination of this drug with ascorbic acid and other vitamins is advisable. Also, Amizon® can be administered simultaneously with the use of recombinant interferon.

Special instructions

Care should be taken to prescribe the drug to patients with thyroid diseases, especially with hyperthyroidism.

The drug contains lactose, therefore, patients with rare hereditary forms of galactose intolerance, lactase deficiency or glucose-galactose malabsorption syndrome should not use the drug.

Application during pregnancy or lactation

Application in the II and III trimester of pregnancy is possible only as directed by a doctor. There are no data on the use of women who are breastfeeding.

Features of the effect of the drug on the ability to drive vehicles and potentially dangerous mechanisms

Taking Amizone® does not affect the ability to drive vehicles or work with other mechanisms.

Overdose

No cases of overdose with Amizon® have been reported. In case of an overdose, an increase in the manifestations of side reactions is possible: staining of the mucous membranes in brown, vomiting, abdominal pain and diarrhea. There may be the development of edema, erythema, acne-like and bullous eruptions, and fever.

Treatment: gastric lavage, symptomatic treatment

Storage conditions

Store in a dark place at a temperature not exceeding 25 ºС.
Keep out of the reach of children!

Shelf life – 3 years

Do not use the drug after the expiration date.

Additional information